Keith Loria is a contributing writer to Medical Economics.
Can remote patient monitoring enhance your practice?
“[The ability of] remote patient monitoring to provide targeted clinical information to physicians and elevate critical information for review and earlier intervention is enhancing patient communication and care delivery,” said Jim Brown, MD.
What are the potential legal risks of telehealth?
Telemedicine risks can be managed by staying informed and educated.
How should you handle a medical board complaint?
“Physicians should take medical board complaints far more seriously than a medical malpractice complaint,” said attorney Alex Keoskey.
Advice on evaluating new technology purchases for your practice
“One has to be very careful about purchasing any kind of technology — especially ones that the patient will pay cash out of their pocket for,” said urologist Clifford Gluck, MD. “That’s why it’s important to get the experience of others who have used the technology and to look at the literature to see what there is in terms of scientific evidence.”
Why private equity is right for some, not all, practices
Private equity firms’ acquisition of physician practices has escalated in recent years, and urology practices are currently garnering great interest due to an increased demand for services from an aging population and a low supply of urologists.
How four generations of physicians can work together
Having four generations of physicians working in the same practice is both a blessing and a significant source of complications, said Haydn Shaw, CSP, at the LUGPA annual meeting in Chicago.
Protecting against cyber risk: Solutions are available
How benchmarking helps manage your time, identify problem areas
Cass Schaedig, vice president of provider analytics, ION Solutions for AmerisourceBergen, talks with Urology Times about the value of benchmarking in patient care, practice management, and health policy.
AUA, ASTRO, SUO release localized PCa guideline
Among the guideline’s recommendations is that active surveillance should serve as the preferred method of care for low-risk localized prostate cancer.
What’s new in updated brachytherapy guideline
The update provides evidence-based recommendations for different patient risk groups and specifies the most effective forms of the treatment for patients with prostate cancer.
Rheumatologic side effects possible with immunotherapies
Cancer patients taking certain immunotherapy drugs may be more susceptible to developing autoimmune joint and tissue diseases, including inflammatory arthritis, according to a recent study.
Genetic predictors could improve PSA accuracy
A recent study has found that genetic predictors of normal PSA levels in healthy men could be used to improve the accuracy of PSA-based prostate cancer screening.
New study supports MET for larger ureteric stones
A recent review of medical literature adds to the debate surrounding medical expulsive therapy for stone disease.
Study examines link between inflammation, prostate Ca
Researchers at UCLA have discovered a previously unrecognized type of progenitor cell in inflamed areas of the prostate that have the ability to initiate cancer in response to genetic changes.
Aerobic exercise boosts testosterone levels
Overweight and obese men who participated in 12 weeks of aerobic exercise saw significantly increased testosterone levels, a recent study found.
Polycythemia risk evaluated in patients on TRT pellets
Researchers evaluated mean hematocrit before and after pellet implantation in a cohort of 97 patients.
Persistent decline in renal function seen after first stone case
“Our research shows that the implications of kidney stones may go beyond the discomfort they are so often associated with,” says co-lead author Andrew Rule, MD.
Is 1.5 the new magic number for PSA screening?
A new approach to prostate cancer screening has been proposed by investigators who claim the idea of informed decision-making by primary care physicians is not working when it comes to PSA testing.
Has ordering of PSA screening dropped among PCPs?
An examination of data involving more than 63,000 PSA tests ordered by primary care physicians reveals some surprising findings.
Upbringing, socioeconomic status linked to PCa
A recent study shows children born to high-status parents have a higher incidence rate of developing prostate and other cancers in later life.
Researchers validate robotic cystectomy quality tool
A team from Roswell Park Cancer Institute has developed and validated a quality assessment tool based on prospectively collected data on robot-assisted cystectomy.
Active surveillance: A potential role in metastatic RCC?
Results from a recent prospective trial suggest that active surveillance may be suitable for some patients with advanced renal cell carcinoma.
2 Clarke Drive Cranbury, NJ 08512